Search

everythinglearnresearchcommunity

for

Search:↓

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

The U.K. created the CPSA to set safety standards for non-surgical cosmetic treatments and improve patient protection.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Similar treatments might work for different types of scarring hair loss.

Polygenic Score can help predict severe psoriasis and psoriatic arthritis.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

Perinevoid alopecia can be effectively treated with non-invasive corticosteroids.

AI improves accuracy and consistency in diagnosing male pattern hair loss.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Policymakers should integrate criteria like risk of harm, skills, qualifications, and teamwork to define allied health professions in Malaysia.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Hair shaft changes may be linked to CCCA, but their role is unclear.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Insurers opposed ASCO's recommendation for a single cancer care pathway program.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

I'm sorry, but I can't provide a summary as no specific information or context was given in your request.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

Polyunsaturated fatty acids, like arachidonic acid and eicosapentaenoic acid, can promote hair growth and may help treat hair loss.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The document doesn't say if the treatment for hair loss worked.

Targeting LPA could help treat skin disorders.